Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study - Wikidata - awgldk - TriplyDB

Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study

Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study

http://www.wikidata.org/entity/Q28200506

about

Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding Management of bleeding in patients treated with direct oral anticoagulants Combining aspirin with antithrombotic agents Data Resource Profile: Danish online drug use statistics (MEDSTAT).Adverse drug events associated with vitamin K antagonists: factors of therapeutic imbalance.Factors predicting a positive capsule endoscopy in past overt obscure gastrointestinal bleeding: a multicenter retrospective study Prediction of bleeding risk in patients taking vitamin K antagonists using thrombin generation testing.Effect modification, interaction and mediation: an overview of theoretical insights for clinical investigators.Effect of Low-dose, Enteric Coated Aspirin on Gastrointestinal Bleeding in Patients with Coronary Artery Disease Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes Use of proton pump inhibitors after antireflux surgery: a nationwide register-based follow-up study.Gastrointestinal comorbidities associated with atrial fibrillation.Warfarin-associated bleeding events and concomitant use of potentially interacting medicines reported to the Norwegian spontaneous reporting system Long-term use of aspirin and the risk of gastrointestinal bleeding.Risk factors and complications following percutaneous endoscopic gastrostomy: a case series of 1041 patients.Upper endoscopy in patients with acute myocardial infarction and upper gastrointestinal bleeding: results of a decision analysis Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin Clinical evidence of interaction between clopidogrel and proton pump inhibitors Potential therapeutic competition in community-living older adults in the U.S.: use of medications that may adversely affect a coexisting condition.Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes.Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy Long-term efficacy and safety of rabeprazole in patients taking low-dose aspirin with a history of peptic ulcers: a phase 2/3, randomized, parallel-group, multicenter, extension clinical trial The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial.Investigation of Gastroduodenal Mucosal Injury in Japanese Asymptomatic Antiplatelet Drug Users Recent developments in nitric oxide donor drugs.Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies.Characteristics of hemorrhagic peptic ulcers in patients receiving antithrombotic/nonsteroidal antiinflammatory drug therapy Natural history of bleeding and characteristics of early bleeders among warfarin initiators - a cohort study in Finland.Upper gastrointestinal bleeding: incidence, etiology and outcomes in a population-based setting Gastrointestinal events with clopidogrel: a nationwide population-based cohort study.Spironolactone use and the risk of upper gastrointestinal bleeding: a population-based case-control study.The impact of bleeding in patients with acute coronary syndromes: how to optimize the benefits of treatment and minimize the risk.Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARD Characteristics of the small bowel lesions detected by capsule endoscopy in patients with chronic kidney disease.Do statins protect against upper gastrointestinal bleeding?The role of antiplatelet therapy in the management of ischemic stroke: implementation of guidelines in current practice.Simultaneous intrahepatic and subgaleal hemorrhage in antiphospholipid syndrome following anticoagulation therapy Drug interaction between clopidogrel and proton pump inhibitors.Impact of aspirin, NSAIDs, warfarin, corticosteroids and SSRIs on the site and outcome of non-variceal upper and lower gastrointestinal bleeding.Combination of low-dose aspirin and thienopyridine exacerbates small bowel injury.

P2860

Q22306044-9CD8C7F0-A108-4E51-BF24-5A5EE24767E3 Q26740258-69680739-267C-42E7-A811-D15C3AD2C372 Q28200615-5D601C6B-96F0-4DEE-BD1C-039940F96932 Q31145026-7A9763DE-AE1D-44A2-A720-CC4D6C00C06A Q33162458-F492BFB3-3457-4764-B8B7-4F34492548F6 Q33554541-616E2F40-30BB-41FB-AEF4-D5CE3269CA62 Q33637902-E507CCE5-BE0A-4322-A3EF-5A88ACBB2D6E Q33812197-750C491E-94A5-4805-ABE9-479B956ACBBD Q33855588-21019320-C851-4235-BAC1-6C6C097B6ADF Q34174915-3D97E4FE-B05E-4856-AFF6-2961606B2667 Q34237263-28067A04-B0F8-414A-8D49-A08B5DA17780 Q34409701-C2653E5E-1067-45AD-8708-98571B052544 Q34580625-883D6771-CCFF-4860-B1FA-D2CBFEA33D2F Q34628874-B8862109-4734-4193-A6F0-51E98F42FE1D Q34938898-E2E10BA1-9FA9-43ED-A220-5A31D8F8C386 Q35024907-8A124E43-CB33-4749-8FC5-9A009718C951 Q35026472-0019A192-C78A-40A4-9D06-32F7813BF485 Q35033722-7296437D-B6FE-41BE-A24D-14B24444F05B Q35107345-31C68E86-7A38-4D4C-8543-6ACB04F68564 Q35117393-20DA6792-0708-4B2C-9710-3D4A131F7CE9 Q35373624-11E27149-6F06-4FFB-9AAF-CE540B354FC7 Q35678985-CF43B894-90C9-48AD-B5B5-1A760EDB4DAE Q35828322-EBE05DC7-F2A3-4504-B76C-E8E121886825 Q35857875-62738D40-029B-46D3-B269-1F4D51832489 Q36052815-26AD65CA-B089-4A79-8C97-2E81A6489FEC Q36094923-8E714D2E-6E2A-4CFD-A30A-93FD0E232E28 Q36385154-F4F82D01-A8F2-418C-AE66-FC46963B03E3 Q36575256-B59CA1DA-47E8-4253-AFBE-F516496CE699 Q36733540-FBE6B52A-C6D4-4212-951B-D1F3FFA66499 Q36734102-7A431D44-0FB8-4A58-9361-F70C2AEA4923 Q36803434-71E4A335-26DA-4E3B-87E6-61061B2648AE Q36861495-7642ECCD-EE9C-4AE0-B251-D28789C80D46 Q36866370-9A45E1FE-C505-48A9-9DE8-2E7878B53E04 Q37162982-4987183E-6ED3-488A-8ACB-6E4B47F10626 Q37184446-22FEA1FA-DD40-49BE-8E10-34C98A9630C0 Q37204401-8FD1A50C-D6E7-45C5-9F8C-4FA789065D89 Q37233852-02DF7B28-A09E-4141-AFC7-2E1F17940930 Q37697780-00F9B6B4-E217-40D1-A97A-0E002598F0E8 Q37778818-E66A53D8-DF49-4340-BD63-C3ED871AB92B Q37816448-9EE3234F-1047-40C6-AD2E-1425D1A4FB33

P2860

Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study

http://www.wikidata.org/entity/Q28200506

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Use of single and combined ant ...... ation based case-control study

@ast

Use of single and combined ant ...... ation based case-control study

@en

Use of single and combined ant ...... ation based case-control study

@nl

type

label

Use of single and combined ant ...... ation based case-control study

@ast

Use of single and combined ant ...... ation based case-control study

@en

Use of single and combined ant ...... ation based case-control study

@nl

prefLabel

Use of single and combined ant ...... ation based case-control study

@ast

Use of single and combined ant ...... ation based case-control study

@en

Use of single and combined ant ...... ation based case-control study

@nl

P1433

Q28200506-3EC4AD33-0E30-47C0-B926-9919F19A97E1

P1476

Q28200506-BAE1C563-53CD-48CF-9D12-1C72BBB5B6E3

P2093

Q28200506-2411B771-59D8-4368-9A63-F2A4E527BAE1

Q28200506-6B91B3BD-70F9-4EE1-B2A7-61641AF4DACD

Q28200506-751B754E-82C2-49CE-9A55-26CDEDC81F25

Q28200506-9B4D220C-0BD5-487F-8C38-8B68D2F6FC75

Q28200506-AAFEB184-3F11-4C59-8310-95450422D992

Q28200506-ABD097A7-EE50-4ACC-B56D-D97117F26054

Q28200506-BA56D70F-8C10-4014-AF05-E611FB6FE1CF

P2860

Q28200506-03A0F2BA-20C5-4F6A-A324-789622A5AB33

Q28200506-121432BB-EE71-4E66-A501-A6708E847994

Q28200506-3CD6FAFF-1B88-43A5-AC2C-82D2C0A444A1

Q28200506-40EC8351-2C35-4706-B430-37152AFE4323

Q28200506-54DB91C5-07AF-4313-9578-D188BD776435

Q28200506-57D5A67A-9159-4843-80A5-B3A7A713232A

Q28200506-7409FD76-377C-417F-ACB9-C508EA51E49A

Q28200506-85C11901-CCC4-4A94-A87A-ED47A9E7767D

Q28200506-949CF965-7F0D-4F42-950E-9C29790DE559

Q28200506-9C80BDD7-8D02-40B7-A693-DE7712CCA462

P304

Q28200506-B9F62955-E9E9-40C9-AC9D-A42DBAB9CD07

P31

Q28200506-1DAC1605-0FD2-4B4B-AD60-F11C21352EF7

P3181

Q28200506-4E368B63-C7F3-4332-B247-1D62C772ACE1

P356

Q28200506-B7107D10-5363-482F-B1E4-84AA5132B3C3

P407

Q28200506-E85BE2EB-36E0-46DF-B9D0-D839981FBD66

P433

Q28200506-1D920DA7-36B6-4108-BEA2-5FAE6A66356F

P478

Q28200506-D27C2BC1-655B-4220-ADA7-5CD72497C20F

P50

Q28200506-FE85ECC3-B1DC-42A0-BED9-EBC5A1614626

P577

Q28200506-0EC2481E-5FF3-4A57-998D-DBAB797F4FE2

P5875

Q28200506-8A379875-B0A5-41C5-857B-54DE238DE178

P698

Q28200506-0B7807C0-B025-44E6-AFC2-D901262BACE3

P932

Q28200506-B433D36F-A939-4443-B9D8-B49E4A3B5C60

P3181

P356

BMJ.38947.697558.AE

P1433

P1476

Use of single and combined ant ...... ation based case-control study

@en

P2093

Alin Andries

http://www.w3.org/2001/XMLSchema#string

Annmarie Touborg Lassen

http://www.w3.org/2001/XMLSchema#string

Birthe Søgaard Andersen

http://www.w3.org/2001/XMLSchema#string

Claus Aalykke

http://www.w3.org/2001/XMLSchema#string

Jane Møller Hansen

http://www.w3.org/2001/XMLSchema#string

Michael Dall

http://www.w3.org/2001/XMLSchema#string

Morten Andersen

http://www.w3.org/2001/XMLSchema#string

P2860

Expressing the magnitude of adverse effects in case-control studies: "the number of patients needed to be treated for one additional patient to be harmed"

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study

Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease

Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction

Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study

Low-dose aspirin for the prevention of atherothrombosis

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

P304

726

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2620579

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/BMJ.38947.697558.AE

http://www.w3.org/2001/XMLSchema#string

P407

P433

7571

http://www.w3.org/2001/XMLSchema#string

P478

333

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6809359

http://www.w3.org/2001/XMLSchema#string

P698

16984924

http://www.w3.org/2001/XMLSchema#string

P932

1592384

http://www.w3.org/2001/XMLSchema#string